A detailed history of Spears Abacus Advisors LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 27,317 shares of BLFS stock, worth $739,198. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,317
Previous 27,317 -0.0%
Holding current value
$739,198
Previous $585,000 16.75%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$15.14 - $22.99 $529 - $804
-35 Reduced 0.13%
27,317 $585,000
Q3 2023

Nov 21, 2023

SELL
$10.81 - $22.96 $15,674 - $33,292
-1,450 Reduced 5.03%
27,352 $377,000
Q2 2023

Aug 14, 2023

SELL
$17.19 - $24.34 $4,813 - $6,815
-280 Reduced 0.96%
28,802 $636,000
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $425,760 - $776,489
29,082 New
29,082 $662,000
Q2 2022

Aug 08, 2022

BUY
$10.54 - $24.2 $63,239 - $145,200
6,000 Added 25.69%
29,352 $405,000
Q1 2022

May 13, 2022

BUY
$20.81 - $37.29 $4,349 - $7,793
209 Added 0.9%
23,352 $531,000
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $20,255 - $35,949
614 Added 2.73%
23,143 $863,000
Q3 2021

Nov 15, 2021

SELL
$42.03 - $60.5 $172,407 - $248,171
-4,102 Reduced 15.4%
22,529 $953,000
Q2 2021

Aug 09, 2021

SELL
$29.51 - $44.62 $16,525 - $24,987
-560 Reduced 2.06%
26,631 $1.19 Million
Q1 2021

May 14, 2021

BUY
$32.95 - $44.24 $1,581 - $2,123
48 Added 0.18%
27,191 $979,000
Q4 2020

Feb 12, 2021

BUY
$27.5 - $45.75 $29,452 - $48,998
1,071 Added 4.11%
27,143 $1.08 Million
Q2 2020

Aug 12, 2020

BUY
$9.2 - $17.06 $1,931 - $3,582
210 Added 0.81%
26,072 $426,000
Q1 2020

May 15, 2020

BUY
$8.36 - $17.03 $65,166 - $132,748
7,795 Added 43.14%
25,862 $246,000
Q4 2019

Feb 14, 2020

BUY
$14.59 - $18.9 $65,173 - $84,426
4,467 Added 32.85%
18,067 $292,000
Q1 2019

May 14, 2019

BUY
$10.9 - $21.26 $148,240 - $289,136
13,600 New
13,600 $243,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.16B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.